New Data Demonstrate the Health Economic Benefits of Nevro’s High-Frequency Spinal Cord Stimulation Therapy

Our Bureau

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new data validating the health economic benefits of 10 kHz Therapy™, Nevro’s proprietary high-frequency,10 kHz spinal cord stimulation (SCS) therapy. This data was derived […]

Crown Aesthetics Announces Launch Expansion of BIOJUVE™ Living Skin Biome Care into the United Kingdom, Ireland, and Germany

Our Bureau

Crown Aesthetics (“Crown”), a division of Crown Laboratories, Inc., is excited to announce the launch of its newest innovation, BIOJUVE™, in the United Kingdom, Ireland and Germany, the largest aesthetic market in Europe. BIOJUVE is a novel skin biome brand that uses a clinically-proven, living microbe technology to optimize the […]

RedHill Announces FDA sNDA Approval for Talicia®

Our Bureau

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced the U.S. Food and Drug Administration’s (FDA) approval of its supplemental new drug application (sNDA) for Talicia[3], allowing a change to a more flexible three times daily (TID), taken at least 4 hours apart with food, […]

SD Biosensor Inc. Held an ESG Management Proclamation Ceremony Focusing on ‘Sustainable Growth for People and the Earth’

Our Bureau

SD Biosensor, Inc. (KQ137310), South Korea’s global in-vitro diagnostics company, announced on September 15 that it held a proclamation ceremony for ESG (Environmental, Social and Corporate Governance) management while executives and employees took part at its headquarters. In the proclamation ceremony, the executives and employees from the Korean headquarters, European […]

Subscribe Now